Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2328)
All Articles published online
|
Jun 14, 2009 (publication date) through Jan 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rosati G, Ferrara D, Manzione L. New perspectives in the treatment of advanced or metastatic gastric cancer. World J Gastroenterol 2009; 15(22): 2689-2692 [PMID: 19522017 DOI: 10.3748/wjg.15.2689] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i22/2689.htm |
| Number | Citing Articles |
| 1 |
Wang Ma, Ming Gao, Wei He, Qingxia Fan. Oxaliplatin and teniposide can inhibit the proliferation and induce the apoptosis of gastric cancer cell line BGC-823 synergistically. The Chinese-German Journal of Clinical Oncology 2010; 9(3): 149 doi: 10.1007/s10330-009-0190-8
|
| 2 |
Károly Lapis. Gazdavédő peptidek és peptidomimetikumok, mint a rákterápia potenciális új eszközei. Magyar Onkológia 2010; 54(1): 47 doi: 10.1556/MOnkol.54.2010.1.7
|
| 3 |
Seung Tae Kim, Jeeyun Lee, Kyu Taek Lee, Jong Kyun Lee, Kwang Hyuk Lee, Seong-Ho Choi, Jin-Seok Heo, Dong Wook Choi, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Young Suk Park, Won Ki Kang. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater. Medical Oncology 2010; 27(4): 1149 doi: 10.1007/s12032-009-9351-4
|
| 4 |
Xiaowan Chen, Guoli Wang, Xiaoli Lu, Peng Gao, Yongxi Song, Jingxu Sun, Ailin Li, Yingying Xu, Huimian Xu, Zhenning Wang. Polymorphisms and haplotypes of the miR-148/152 family are associated with the risk and clinicopathological features of gastric cancer in a Northern Chinese population. Mutagenesis 2014; 29(6): 401 doi: 10.1093/mutage/geu050
|
| 5 |
Jie Gao, Ningning Sai, Chengqin Wang, Xiehuang Sheng, Qianqian Shao, Chengjun Zhou, Yanqiu Shi, Shanzhen Sun, Xun Qu, Changjun Zhu. Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumor Biology 2011; 32(1): 53 doi: 10.1007/s13277-010-0090-0
|
| 6 |
Cong Wang, Dong-Jian Song, Zhi-Li Xu, Shu-Ping Xie, Jun-Hong Hu. A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma. Experimental & Molecular Medicine 2017; 49(9): e383 doi: 10.1038/emm.2017.170
|
| 7 |
Xuan Liu, Li-juan Xiu, Jian-peng Jiao, Jing Zhao, Ying Zhao, Ye Lu, Jun Shi, Yong-jin Li, Min Ye, Yu-fang Gu, Xiao-wei Wang, Jing-yu Xu, Ci-an Zhang, Yong-ying Liu, Yun Luo, Xiao-qiang Yue. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: a retrospective clinical analysis. Journal of Integrative Medicine 2017; 15(6): 469 doi: 10.1016/S2095-4964(17)60377-7
|
| 8 |
Jing-Han Li, Dan-Ying Zhang, Ji-Min Zhu, Ling Dong. Clinical applications and perspectives of circulating tumor DNA in gastric cancer. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03209-4
|
| 9 |
Kai-Yuan Lin, Lu-Hai Wang, You-Cheng Hseu, Chia-Lang Fang, Hsin-Ling Yang, K.J. Senthil Kumar, Chein Tai, Yih-Huei Uen. Clinical Significance of Increased Guanine Nucleotide Exchange Factor Vav3 Expression in Human Gastric Cancer. Molecular Cancer Research 2012; 10(6): 750 doi: 10.1158/1541-7786.MCR-11-0598-T
|
| 10 |
Pawel Zayakin, Guntis Ancāns, Karīna Siliņa, Irēna Meistere, Zane Kalniņa, Diāna Andrejeva, Edgars Endzeliņš, Lāsma Ivanova, Angelina Pismennaja, Agnese Ruskule, Simona Doniņa, Thomas Wex, Peter Malfertheiner, Mārcis Leja, Aija Linē. Tumor‐associated autoantibody signature for the early detection of gastric cancer. International Journal of Cancer 2013; 132(1): 137 doi: 10.1002/ijc.27667
|
| 11 |
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis. International Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
|
| 12 |
S. Chen, Z. Zheng, J. Tang, X. Lin, X. Wang, J. Lin. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population. Carcinogenesis 2013; 34(5): 1018 doi: 10.1093/carcin/bgt010
|
| 13 |
Sudeep Karve, Maria Lorenzo, Astra M Liepa, Lisa M Hess, James A Kaye, Brian Calingaert. Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database. Journal of Gastric Cancer 2015; 15(2): 87 doi: 10.5230/jgc.2015.15.2.87
|
| 14 |
Minkyo Song, M. Constanza Camargo, Stephanie J. Weinstein, Ana F. Best, Satu Männistö, Demetrius Albanes, Charles S. Rabkin. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population. Gastric Cancer 2018; 21(5): 729 doi: 10.1007/s10120-018-0807-0
|
| 15 |
Ch'angbum Rim, Jung-Ae Lee, Soojung Gong, Dong Wook Kang, Heebum Yang, Hyun Young Han, Nae Yu Kim. A Case of Long-Term Complete Remission of Advanced Gastric Adenocarcinoma with Liver Metastasis. Journal of Gastric Cancer 2016; 16(2): 115 doi: 10.5230/jgc.2016.16.2.115
|
| 16 |
Shuaibing Wang, Jiejie Qin, Hua Ye, Keyan Wang, Jianxiang Shi, Yan Ma, Yitao Duan, Chunhua Song, Xiao Wang, Liping Dai, Kaijuan Wang, Peng Wang, Jianying Zhang. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer. OncoImmunology 2018; : e1452582 doi: 10.1080/2162402X.2018.1452582
|
| 17 |
M. Song, M. C. Camargo, S. J. Weinstein, G. Murphy, N. D. Freedman, J. Koshiol, R. Z. Stolzenberg‐Solomon, C. C. Abnet, S. Männistö, D. Albanes, C. S. Rabkin. Serum pepsinogen 1 and anti‐Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Alimentary Pharmacology & Therapeutics 2018; 47(4): 494 doi: 10.1111/apt.14471
|
| 18 |
Jing Zhang, Jiao Jiang, Xiaotian Wu. MATHEMATICAL SOLUTION OF A PHARMACOKINETIC MODEL WITH SIMULTANEOUS FIRST-ORDER AND HILL-TYPE ELIMINATION. Journal of Applied Analysis & Computation 2023; 13(2): 623 doi: 10.11948/20210365
|
| 19 |
Sávia Raquel Costa Normando, Pamela de Oliveira Delgado, Ana Katherine Soares Barbosa Rodrigues, Waldec Jorge David Filho, Fernando Luiz Affonso Fonseca, Felipe José Silva Melo Cruz, Auro del Giglio. Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy. BMC Clinical Pathology 2018; 18(1) doi: 10.1186/s12907-018-0079-y
|
| 20 |
Hyun Woo Chung, Eun Jeong Lee, Yo-Han Cho, So Young Yoon, Young So, Sung-Yong Kim, Mark Hong Lee, Jeong Hwan Kim, Sun-Young Lee, In-Kyung Sung, Hyung-Seok Park, Moon-Won Yoo, Kyung-Yung Lee. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2010; 136(12): 1929 doi: 10.1007/s00432-010-0852-5
|
| 21 |
Zane Kalniņa, Irēna Meistere, Ilze Kikuste, Ivars Tolmanis, Pawel Zayakin, Aija Linē. Emerging blood-based biomarkers for detection of gastric cancer. World Journal of Gastroenterology 2015; 21(41): 11636-11653 doi: 10.3748/wjg.v21.i41.11636
|
| 22 |
Nicholas A. Coupe, Deme Karikios, Shanley Chong, June Yap, Weng Ng, Neil Merrett, Michael Lin. Metabolic information on staging FDG-PET–CT as a prognostic tool in the evaluation of 97 patients with gastric cancer. Annals of Nuclear Medicine 2014; 28(2): 128 doi: 10.1007/s12149-013-0791-8
|
| 23 |
Dong-ta Zhong, Ri-ping Wu, Xin-li Wang, Xiao-bing Huang, Meng-xin Lin, Yan-qin Lan, Qiang Chen. Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer. Pathology & Oncology Research 2015; 21(4): 867 doi: 10.1007/s12253-015-9903-1
|
| 24 |
Zhan-Dong Zhang, Ye Kong, Wei Yang, Bin Zhang, Yong-Lei Zhang, Er-Min Ma, Hong-Xing Liu, Xiao-Bin Chen, Ya-Wei Hua. Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-115
|
| 25 |
LIJUN WANG, QUANMAO SONG, JINPENG LI, XIAOHUA CHEN. S-1 treatment leading to complete remission of advanced duodenal adenocarcinoma: A case report. Molecular and Clinical Oncology 2015; 3(5): 1184 doi: 10.3892/mco.2015.607
|
| 26 |
Tao Jiang, Hongjun Zhang, Xiguang Liu, Hao Song, Ruyong Yao, Jianbin Li, Yuanyuan Zhao. Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC-7901 cells. Oncology Letters 2016; 12(6): 4538 doi: 10.3892/ol.2016.5293
|
| 27 |
Masahiko Nishiyama, Satoru Wada. Docetaxel: its role in current and future treatments for advanced gastric cancer. Gastric Cancer 2009; 12(3): 132 doi: 10.1007/s10120-009-0521-z
|
| 28 |
Rui Li, Lingyan Yuan, Jin Wang, Jiejun Wang. Co-expression of erythropoietin receptor with human epidermal growth factor 2 may counteract trastuzumab inhibition in gastric cancer. Medical Hypotheses 2011; 77(6): 948 doi: 10.1016/j.mehy.2011.07.021
|
| 29 |
Song Liu, Ying Zhu, Lie‑Wen Lin, Shun‑Kai Ding, Xiao‑Cong Lin, Ke‑Li Zhong, Kai Pan, Yong Dai. The composition and variation of the BCR CDR3s in gastric cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8677
|